Pathologist Petitions FDA to Halt Pfizer Emergency Use Authorization Until Vaccine Efficacy Confirmed
The major reason for petitioning the FDA for a stay of action is that the Phase 2/3 clinical trial of the Pfizer vaccine used a presumptive RT-qPCR diagnostic test.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
